Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000708

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
76.0 GB
File formats
  • FASTQ
  • BAM
Research
hum0358
Date published
2022-12-02
Date modified
2022-12-02
DDBJ Search
JGAD000708 (opens in a new tab)
JGA Study
JGAS000582 (opens in a new tab)

Analysis method

WES

Materials and participants
cervical cancer (ICD10: C539)
4 cases: 8 tumor samples, 2 peripheral blood samples, 2 normal areas near the tumor
  • Health status
    Affected
  • Subject count
    15 (Sample)
Disease
cervical cancer (C539)
Sample description
DNAs extracted from tumors, tumor-derived organoids, peripheral blood cells, or normal areas near the tumor
  • Tissue
    Organoid, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
Twist Comprehensive Exome Panel
Fragmentation
Ultrasonic fragmentation (Covaris S220)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh38
Mapping
bwa, bowtie2
Mapping quality
≧30
Coverage (depth)
168x
39–318x (Range)
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
cervical cancer (ICD10: C539)
5 cases: multiple sampling each from within the same tumor for a total of 77 samples
  • Health status
    Mixed
  • Subject count
    104 (Sample)
Disease
cervical cancer (C539)
Sample description
RNAs extracted from tumor tissues, non-tumor tissues, patient-derived organoids, or siRNA-mediated knockdown samples of NIKS18
  • Tissue
    Organoid
  • Tumor / normal
    Mixed
Cell line
NIKS18
Sample provider
NIKS18 is NIKS, which is a human keratinocyte cell line (ATCC CRL-12191), contain HPV18 genome as episomes
Experimental method
RNA-seq
Target
N/A
Reagent kit
Nextera XT DNA Library Prep Kit
Fragmentation
Nextera XT transposome
Platform
Illumina MiSeq
Read type
Paired-end
Read length
75 bp
Data use policy
NBDC data sharing policy (JGAP000001)